Global Cell Therapy Manufacturing Market Research Report 2022
Table of Contents1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cell Therapy Manufacturing Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Autologous
1.2.3 Allogenic
1.3 Market by Application
1.3.1 Global Cell Therapy Manufacturing Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 HIV
1.3.3 Autoimmune Disorders
1.3.4 Immune Deficiencies
1.3.5 Cancer
1.3.6 Neurological Disorders
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Cell Therapy Manufacturing Market Perspective (2017-2028)
2.2 Cell Therapy Manufacturing Growth Trends by Region
2.2.1 Cell Therapy Manufacturing Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Cell Therapy Manufacturing Historic Market Size by Region (2017-2022)
2.2.3 Cell Therapy Manufacturing Forecasted Market Size by Region (2023-2028)
2.3 Cell Therapy Manufacturing Market Dynamics
2.3.1 Cell Therapy Manufacturing Industry Trends
2.3.2 Cell Therapy Manufacturing Market Drivers
2.3.3 Cell Therapy Manufacturing Market Challenges
2.3.4 Cell Therapy Manufacturing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cell Therapy Manufacturing Players by Revenue
3.1.1 Global Top Cell Therapy Manufacturing Players by Revenue (2017-2022)
3.1.2 Global Cell Therapy Manufacturing Revenue Market Share by Players (2017-2022)
3.2 Global Cell Therapy Manufacturing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Cell Therapy Manufacturing Revenue
3.4 Global Cell Therapy Manufacturing Market Concentration Ratio
3.4.1 Global Cell Therapy Manufacturing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cell Therapy Manufacturing Revenue in 2021
3.5 Cell Therapy Manufacturing Key Players Head office and Area Served
3.6 Key Players Cell Therapy Manufacturing Product Solution and Service
3.7 Date of Enter into Cell Therapy Manufacturing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Cell Therapy Manufacturing Breakdown Data by Type
4.1 Global Cell Therapy Manufacturing Historic Market Size by Type (2017-2022)
4.2 Global Cell Therapy Manufacturing Forecasted Market Size by Type (2023-2028)
5 Cell Therapy Manufacturing Breakdown Data by Application
5.1 Global Cell Therapy Manufacturing Historic Market Size by Application (2017-2022)
5.2 Global Cell Therapy Manufacturing Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Cell Therapy Manufacturing Market Size (2017-2028)
6.2 North America Cell Therapy Manufacturing Market Size by Country (2017-2022)
6.3 North America Cell Therapy Manufacturing Market Size by Country (2023-2028)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Cell Therapy Manufacturing Market Size (2017-2028)
7.2 Europe Cell Therapy Manufacturing Market Size by Country (2017-2022)
7.3 Europe Cell Therapy Manufacturing Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Cell Therapy Manufacturing Market Size (2017-2028)
8.2 Asia-Pacific Cell Therapy Manufacturing Market Size by Country (2017-2022)
8.3 Asia-Pacific Cell Therapy Manufacturing Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Cell Therapy Manufacturing Market Size (2017-2028)
9.2 Latin America Cell Therapy Manufacturing Market Size by Country (2017-2022)
9.3 Latin America Cell Therapy Manufacturing Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cell Therapy Manufacturing Market Size (2017-2028)
10.2 Middle East & Africa Cell Therapy Manufacturing Market Size by Country (2017-2022)
10.3 Middle East & Africa Cell Therapy Manufacturing Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 Merck KGaA
11.1.1 Merck KGaA Company Detail
11.1.2 Merck KGaA Business Overview
11.1.3 Merck KGaA Cell Therapy Manufacturing Introduction
11.1.4 Merck KGaA Revenue in Cell Therapy Manufacturing Business (2017-2022)
11.1.5 Merck KGaA Recent Development
11.2 Avantor
11.2.1 Avantor Company Detail
11.2.2 Avantor Business Overview
11.2.3 Avantor Cell Therapy Manufacturing Introduction
11.2.4 Avantor Revenue in Cell Therapy Manufacturing Business (2017-2022)
11.2.5 Avantor Recent Development
11.3 Cell Therapies
11.3.1 Cell Therapies Company Detail
11.3.2 Cell Therapies Business Overview
11.3.3 Cell Therapies Cell Therapy Manufacturing Introduction
11.3.4 Cell Therapies Revenue in Cell Therapy Manufacturing Business (2017-2022)
11.3.5 Cell Therapies Recent Development
11.4 Thermo Fisher Scientific
11.4.1 Thermo Fisher Scientific Company Detail
11.4.2 Thermo Fisher Scientific Business Overview
11.4.3 Thermo Fisher Scientific Cell Therapy Manufacturing Introduction
11.4.4 Thermo Fisher Scientific Revenue in Cell Therapy Manufacturing Business (2017-2022)
11.4.5 Thermo Fisher Scientific Recent Development
11.5 Charles River Laboratories
11.5.1 Charles River Laboratories Company Detail
11.5.2 Charles River Laboratories Business Overview
11.5.3 Charles River Laboratories Cell Therapy Manufacturing Introduction
11.5.4 Charles River Laboratories Revenue in Cell Therapy Manufacturing Business (2017-2022)
11.5.5 Charles River Laboratories Recent Development
11.6 Catalent
11.6.1 Catalent Company Detail
11.6.2 Catalent Business Overview
11.6.3 Catalent Cell Therapy Manufacturing Introduction
11.6.4 Catalent Revenue in Cell Therapy Manufacturing Business (2017-2022)
11.6.5 Catalent Recent Development
11.7 Bio-Techne
11.7.1 Bio-Techne Company Detail
11.7.2 Bio-Techne Business Overview
11.7.3 Bio-Techne Cell Therapy Manufacturing Introduction
11.7.4 Bio-Techne Revenue in Cell Therapy Manufacturing Business (2017-2022)
11.7.5 Bio-Techne Recent Development
11.8 Cytiva
11.8.1 Cytiva Company Detail
11.8.2 Cytiva Business Overview
11.8.3 Cytiva Cell Therapy Manufacturing Introduction
11.8.4 Cytiva Revenue in Cell Therapy Manufacturing Business (2017-2022)
11.8.5 Cytiva Recent Development
11.9 Lonza
11.9.1 Lonza Company Detail
11.9.2 Lonza Business Overview
11.9.3 Lonza Cell Therapy Manufacturing Introduction
11.9.4 Lonza Revenue in Cell Therapy Manufacturing Business (2017-2022)
11.9.5 Lonza Recent Development
11.10 The Discovery Labs
11.10.1 The Discovery Labs Company Detail
11.10.2 The Discovery Labs Business Overview
11.10.3 The Discovery Labs Cell Therapy Manufacturing Introduction
11.10.4 The Discovery Labs Revenue in Cell Therapy Manufacturing Business (2017-2022)
11.10.5 The Discovery Labs Recent Development
11.11 BIOCENTRIQ
11.11.1 BIOCENTRIQ Company Detail
11.11.2 BIOCENTRIQ Business Overview
11.11.3 BIOCENTRIQ Cell Therapy Manufacturing Introduction
11.11.4 BIOCENTRIQ Revenue in Cell Therapy Manufacturing Business (2017-2022)
11.11.5 BIOCENTRIQ Recent Development
11.12 FUJIFILM Diosynth Biotechnologies
11.12.1 FUJIFILM Diosynth Biotechnologies Company Detail
11.12.2 FUJIFILM Diosynth Biotechnologies Business Overview
11.12.3 FUJIFILM Diosynth Biotechnologies Cell Therapy Manufacturing Introduction
11.12.4 FUJIFILM Diosynth Biotechnologies Revenue in Cell Therapy Manufacturing Business (2017-2022)
11.12.5 FUJIFILM Diosynth Biotechnologies Recent Development
11.13 Novartis AG
11.13.1 Novartis AG Company Detail
11.13.2 Novartis AG Business Overview
11.13.3 Novartis AG Cell Therapy Manufacturing Introduction
11.13.4 Novartis AG Revenue in Cell Therapy Manufacturing Business (2017-2022)
11.13.5 Novartis AG Recent Development
11.14 Bristol-Myers Squibb
11.14.1 Bristol-Myers Squibb Company Detail
11.14.2 Bristol-Myers Squibb Business Overview
11.14.3 Bristol-Myers Squibb Cell Therapy Manufacturing Introduction
11.14.4 Bristol-Myers Squibb Revenue in Cell Therapy Manufacturing Business (2017-2022)
11.14.5 Bristol-Myers Squibb Recent Development
11.15 Gilead Sciences
11.15.1 Gilead Sciences Company Detail
11.15.2 Gilead Sciences Business Overview
11.15.3 Gilead Sciences Cell Therapy Manufacturing Introduction
11.15.4 Gilead Sciences Revenue in Cell Therapy Manufacturing Business (2017-2022)
11.15.5 Gilead Sciences Recent Development
11.16 WuXi AppTec
11.16.1 WuXi AppTec Company Detail
11.16.2 WuXi AppTec Business Overview
11.16.3 WuXi AppTec Cell Therapy Manufacturing Introduction
11.16.4 WuXi AppTec Revenue in Cell Therapy Manufacturing Business (2017-2022)
11.16.5 WuXi AppTec Recent Development
11.17 OXGENE
11.17.1 OXGENE Company Detail
11.17.2 OXGENE Business Overview
11.17.3 OXGENE Cell Therapy Manufacturing Introduction
11.17.4 OXGENE Revenue in Cell Therapy Manufacturing Business (2017-2022)
11.17.5 OXGENE Recent Development
11.18 Pharmaron
11.18.1 Pharmaron Company Detail
11.18.2 Pharmaron Business Overview
11.18.3 Pharmaron Cell Therapy Manufacturing Introduction
11.18.4 Pharmaron Revenue in Cell Therapy Manufacturing Business (2017-2022)
11.18.5 Pharmaron Recent Development
11.19 Aldevron
11.19.1 Aldevron Company Detail
11.19.2 Aldevron Business Overview
11.19.3 Aldevron Cell Therapy Manufacturing Introduction
11.19.4 Aldevron Revenue in Cell Therapy Manufacturing Business (2017-2022)
11.19.5 Aldevron Recent Development
11.20 FLODESIGN SONICS
11.20.1 FLODESIGN SONICS Company Detail
11.20.2 FLODESIGN SONICS Business Overview
11.20.3 FLODESIGN SONICS Cell Therapy Manufacturing Introduction
11.20.4 FLODESIGN SONICS Revenue in Cell Therapy Manufacturing Business (2017-2022)
11.20.5 FLODESIGN SONICS Recent Development
11.21 Exothera
11.21.1 Exothera Company Detail
11.21.2 Exothera Business Overview
11.21.3 Exothera Cell Therapy Manufacturing Introduction
11.21.4 Exothera Revenue in Cell Therapy Manufacturing Business (2017-2022)
11.21.5 Exothera Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesTable 1. Global Cell Therapy Manufacturing Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
Table 2. Key Players of Autologous
Table 3. Key Players of Allogenic
Table 4. Global Cell Therapy Manufacturing Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
Table 5. Global Cell Therapy Manufacturing Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 6. Global Cell Therapy Manufacturing Market Size by Region (2017-2022) & (US$ Million)
Table 7. Global Cell Therapy Manufacturing Market Share by Region (2017-2022)
Table 8. Global Cell Therapy Manufacturing Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 9. Global Cell Therapy Manufacturing Market Share by Region (2023-2028)
Table 10. Cell Therapy Manufacturing Market Trends
Table 11. Cell Therapy Manufacturing Market Drivers
Table 12. Cell Therapy Manufacturing Market Challenges
Table 13. Cell Therapy Manufacturing Market Restraints
Table 14. Global Cell Therapy Manufacturing Revenue by Players (2017-2022) & (US$ Million)
Table 15. Global Cell Therapy Manufacturing Market Share by Players (2017-2022)
Table 16. Global Top Cell Therapy Manufacturing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cell Therapy Manufacturing as of 2021)
Table 17. Ranking of Global Top Cell Therapy Manufacturing Companies by Revenue (US$ Million) in 2021
Table 18. Global 5 Largest Players Market Share by Cell Therapy Manufacturing Revenue (CR5 and HHI) & (2017-2022)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Cell Therapy Manufacturing Product Solution and Service
Table 21. Date of Enter into Cell Therapy Manufacturing Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Cell Therapy Manufacturing Market Size by Type (2017-2022) & (US$ Million)
Table 24. Global Cell Therapy Manufacturing Revenue Market Share by Type (2017-2022)
Table 25. Global Cell Therapy Manufacturing Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 26. Global Cell Therapy Manufacturing Revenue Market Share by Type (2023-2028)
Table 27. Global Cell Therapy Manufacturing Market Size by Application (2017-2022) & (US$ Million)
Table 28. Global Cell Therapy Manufacturing Revenue Market Share by Application (2017-2022)
Table 29. Global Cell Therapy Manufacturing Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 30. Global Cell Therapy Manufacturing Revenue Market Share by Application (2023-2028)
Table 31. North America Cell Therapy Manufacturing Market Size by Country (2017-2022) & (US$ Million)
Table 32. North America Cell Therapy Manufacturing Market Size by Country (2023-2028) & (US$ Million)
Table 33. Europe Cell Therapy Manufacturing Market Size by Country (2017-2022) & (US$ Million)
Table 34. Europe Cell Therapy Manufacturing Market Size by Country (2023-2028) & (US$ Million)
Table 35. Asia-Pacific Cell Therapy Manufacturing Market Size by Region (2017-2022) & (US$ Million)
Table 36. Asia-Pacific Cell Therapy Manufacturing Market Size by Region (2023-2028) & (US$ Million)
Table 37. Latin America Cell Therapy Manufacturing Market Size by Country (2017-2022) & (US$ Million)
Table 38. Latin America Cell Therapy Manufacturing Market Size by Country (2023-2028) & (US$ Million)
Table 39. Middle East & Africa Cell Therapy Manufacturing Market Size by Country (2017-2022) & (US$ Million)
Table 40. Middle East & Africa Cell Therapy Manufacturing Market Size by Country (2023-2028) & (US$ Million)
Table 41. Merck KGaA Company Detail
Table 42. Merck KGaA Business Overview
Table 43. Merck KGaA Cell Therapy Manufacturing Product
Table 44. Merck KGaA Revenue in Cell Therapy Manufacturing Business (2017-2022) & (US$ Million)
Table 45. Merck KGaA Recent Development
Table 46. Avantor Company Detail
Table 47. Avantor Business Overview
Table 48. Avantor Cell Therapy Manufacturing Product
Table 49. Avantor Revenue in Cell Therapy Manufacturing Business (2017-2022) & (US$ Million)
Table 50. Avantor Recent Development
Table 51. Cell Therapies Company Detail
Table 52. Cell Therapies Business Overview
Table 53. Cell Therapies Cell Therapy Manufacturing Product
Table 54. Cell Therapies Revenue in Cell Therapy Manufacturing Business (2017-2022) & (US$ Million)
Table 55. Cell Therapies Recent Development
Table 56. Thermo Fisher Scientific Company Detail
Table 57. Thermo Fisher Scientific Business Overview
Table 58. Thermo Fisher Scientific Cell Therapy Manufacturing Product
Table 59. Thermo Fisher Scientific Revenue in Cell Therapy Manufacturing Business (2017-2022) & (US$ Million)
Table 60. Thermo Fisher Scientific Recent Development
Table 61. Charles River Laboratories Company Detail
Table 62. Charles River Laboratories Business Overview
Table 63. Charles River Laboratories Cell Therapy Manufacturing Product
Table 64. Charles River Laboratories Revenue in Cell Therapy Manufacturing Business (2017-2022) & (US$ Million)
Table 65. Charles River Laboratories Recent Development
Table 66. Catalent Company Detail
Table 67. Catalent Business Overview
Table 68. Catalent Cell Therapy Manufacturing Product
Table 69. Catalent Revenue in Cell Therapy Manufacturing Business (2017-2022) & (US$ Million)
Table 70. Catalent Recent Development
Table 71. Bio-Techne Company Detail
Table 72. Bio-Techne Business Overview
Table 73. Bio-Techne Cell Therapy Manufacturing Product
Table 74. Bio-Techne Revenue in Cell Therapy Manufacturing Business (2017-2022) & (US$ Million)
Table 75. Bio-Techne Recent Development
Table 76. Cytiva Company Detail
Table 77. Cytiva Business Overview
Table 78. Cytiva Cell Therapy Manufacturing Product
Table 79. Cytiva Revenue in Cell Therapy Manufacturing Business (2017-2022) & (US$ Million)
Table 80. Cytiva Recent Development
Table 81. Lonza Company Detail
Table 82. Lonza Business Overview
Table 83. Lonza Cell Therapy Manufacturing Product
Table 84. Lonza Revenue in Cell Therapy Manufacturing Business (2017-2022) & (US$ Million)
Table 85. Lonza Recent Development
Table 86. The Discovery Labs Company Detail
Table 87. The Discovery Labs Business Overview
Table 88. The Discovery Labs Cell Therapy Manufacturing Product
Table 89. The Discovery Labs Revenue in Cell Therapy Manufacturing Business (2017-2022) & (US$ Million)
Table 90. The Discovery Labs Recent Development
Table 91. BIOCENTRIQ Company Detail
Table 92. BIOCENTRIQ Business Overview
Table 93. BIOCENTRIQ Cell Therapy ManufacturingProduct
Table 94. BIOCENTRIQ Revenue in Cell Therapy Manufacturing Business (2017-2022) & (US$ Million)
Table 95. BIOCENTRIQ Recent Development
Table 96. FUJIFILM Diosynth Biotechnologies Company Detail
Table 97. FUJIFILM Diosynth Biotechnologies Business Overview
Table 98. FUJIFILM Diosynth Biotechnologies Cell Therapy ManufacturingProduct
Table 99. FUJIFILM Diosynth Biotechnologies Revenue in Cell Therapy Manufacturing Business (2017-2022) & (US$ Million)
Table 100. FUJIFILM Diosynth Biotechnologies Recent Development
Table 101. Novartis AG Company Detail
Table 102. Novartis AG Business Overview
Table 103. Novartis AG Cell Therapy ManufacturingProduct
Table 104. Novartis AG Revenue in Cell Therapy Manufacturing Business (2017-2022) & (US$ Million)
Table 105. Novartis AG Recent Development
Table 106. Bristol-Myers Squibb Company Detail
Table 107. Bristol-Myers Squibb Business Overview
Table 108. Bristol-Myers Squibb Cell Therapy ManufacturingProduct
Table 109. Bristol-Myers Squibb Revenue in Cell Therapy Manufacturing Business (2017-2022) & (US$ Million)
Table 110. Bristol-Myers Squibb Recent Development
Table 111. Gilead Sciences Company Detail
Table 112. Gilead Sciences Business Overview
Table 113. Gilead Sciences Cell Therapy ManufacturingProduct
Table 114. Gilead Sciences Revenue in Cell Therapy Manufacturing Business (2017-2022) & (US$ Million)
Table 115. Gilead Sciences Recent Development
Table 116. WuXi AppTec Company Detail
Table 117. WuXi AppTec Business Overview
Table 118. WuXi AppTec Cell Therapy ManufacturingProduct
Table 119. WuXi AppTec Revenue in Cell Therapy Manufacturing Business (2017-2022) & (US$ Million)
Table 120. WuXi AppTec Recent Development
Table 121. OXGENE Company Detail
Table 122. OXGENE Business Overview
Table 123. OXGENE Cell Therapy ManufacturingProduct
Table 124. OXGENE Revenue in Cell Therapy Manufacturing Business (2017-2022) & (US$ Million)
Table 125. OXGENE Recent Development
Table 126. Pharmaron Company Detail
Table 127. Pharmaron Business Overview
Table 128. Pharmaron Cell Therapy ManufacturingProduct
Table 129. Pharmaron Revenue in Cell Therapy Manufacturing Business (2017-2022) & (US$ Million)
Table 130. Pharmaron Recent Development
Table 131. Aldevron Company Detail
Table 132. Aldevron Business Overview
Table 133. Aldevron Cell Therapy ManufacturingProduct
Table 134. Aldevron Revenue in Cell Therapy Manufacturing Business (2017-2022) & (US$ Million)
Table 135. Aldevron Recent Development
Table 136. FLODESIGN SONICS Company Detail
Table 137. FLODESIGN SONICS Business Overview
Table 138. FLODESIGN SONICS Cell Therapy ManufacturingProduct
Table 139. FLODESIGN SONICS Revenue in Cell Therapy Manufacturing Business (2017-2022) & (US$ Million)
Table 140. FLODESIGN SONICS Recent Development
Table 141. Exothera Company Detail
Table 142. Exothera Business Overview
Table 143. Exothera Cell Therapy ManufacturingProduct
Table 144. Exothera Revenue in Cell Therapy Manufacturing Business (2017-2022) & (US$ Million)
Table 145. Exothera Recent Development
Table 146. Research Programs/Design for This Report
Table 147. Key Data Information from Secondary Sources
Table 148. Key Data Information from Primary Sources
List of FiguresFigure 1. Global Cell Therapy Manufacturing Market Share by Type: 2021 VS 2028
Figure 2. Autologous Features
Figure 3. Allogenic Features
Figure 4. Global Cell Therapy Manufacturing Market Share by Application in 2021 & 2028
Figure 5. HIV Case Studies
Figure 6. Autoimmune Disorders Case Studies
Figure 7. Immune Deficiencies Case Studies
Figure 8. Cancer Case Studies
Figure 9. Neurological Disorders Case Studies
Figure 10. Cell Therapy Manufacturing Report Years Considered
Figure 11. Global Cell Therapy Manufacturing Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 12. Global Cell Therapy Manufacturing Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 13. Global Cell Therapy Manufacturing Market Share by Region: 2021 VS 2028
Figure 14. Global Cell Therapy Manufacturing Market Share by Players in 2021
Figure 15. Global Top Cell Therapy Manufacturing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cell Therapy Manufacturing as of 2021)
Figure 16. The Top 10 and 5 Players Market Share by Cell Therapy Manufacturing Revenue in 2021
Figure 17. North America Cell Therapy Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 18. North America Cell Therapy Manufacturing Market Share by Country (2017-2028)
Figure 19. United States Cell Therapy Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 20. Canada Cell Therapy Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 21. Europe Cell Therapy Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 22. Europe Cell Therapy Manufacturing Market Share by Country (2017-2028)
Figure 23. Germany Cell Therapy Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 24. France Cell Therapy Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 25. U.K. Cell Therapy Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. Italy Cell Therapy Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. Russia Cell Therapy Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. Nordic Countries Cell Therapy Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Asia-Pacific Cell Therapy Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Asia-Pacific Cell Therapy Manufacturing Market Share by Region (2017-2028)
Figure 31. China Cell Therapy Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Japan Cell Therapy Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. South Korea Cell Therapy Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. Southeast Asia Cell Therapy Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. India Cell Therapy Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. Australia Cell Therapy Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. Latin America Cell Therapy Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Latin America Cell Therapy Manufacturing Market Share by Country (2017-2028)
Figure 39. Mexico Cell Therapy Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Brazil Cell Therapy Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Middle East & Africa Cell Therapy Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Middle East & Africa Cell Therapy Manufacturing Market Share by Country (2017-2028)
Figure 43. Turkey Cell Therapy Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 44. Saudi Arabia Cell Therapy Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 45. Merck KGaA Revenue Growth Rate in Cell Therapy Manufacturing Business (2017-2022)
Figure 46. Avantor Revenue Growth Rate in Cell Therapy Manufacturing Business (2017-2022)
Figure 47. Cell Therapies Revenue Growth Rate in Cell Therapy Manufacturing Business (2017-2022)
Figure 48. Thermo Fisher Scientific Revenue Growth Rate in Cell Therapy Manufacturing Business (2017-2022)
Figure 49. Charles River Laboratories Revenue Growth Rate in Cell Therapy Manufacturing Business (2017-2022)
Figure 50. Catalent Revenue Growth Rate in Cell Therapy Manufacturing Business (2017-2022)
Figure 51. Bio-Techne Revenue Growth Rate in Cell Therapy Manufacturing Business (2017-2022)
Figure 52. Cytiva Revenue Growth Rate in Cell Therapy Manufacturing Business (2017-2022)
Figure 53. Lonza Revenue Growth Rate in Cell Therapy Manufacturing Business (2017-2022)
Figure 54. The Discovery Labs Revenue Growth Rate in Cell Therapy Manufacturing Business (2017-2022)
Figure 55. BIOCENTRIQ Revenue Growth Rate in Cell Therapy Manufacturing Business (2017-2022)
Figure 56. FUJIFILM Diosynth Biotechnologies Revenue Growth Rate in Cell Therapy Manufacturing Business (2017-2022)
Figure 57. Novartis AG Revenue Growth Rate in Cell Therapy Manufacturing Business (2017-2022)
Figure 58. Bristol-Myers Squibb Revenue Growth Rate in Cell Therapy Manufacturing Business (2017-2022)
Figure 59. Gilead Sciences Revenue Growth Rate in Cell Therapy Manufacturing Business (2017-2022)
Figure 60. WuXi AppTec Revenue Growth Rate in Cell Therapy Manufacturing Business (2017-2022)
Figure 61. OXGENE Revenue Growth Rate in Cell Therapy Manufacturing Business (2017-2022)
Figure 62. Pharmaron Revenue Growth Rate in Cell Therapy Manufacturing Business (2017-2022)
Figure 63. Aldevron Revenue Growth Rate in Cell Therapy Manufacturing Business (2017-2022)
Figure 64. FLODESIGN SONICS Revenue Growth Rate in Cell Therapy Manufacturing Business (2017-2022)
Figure 65. Exothera Revenue Growth Rate in Cell Therapy Manufacturing Business (2017-2022)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed